Last reviewed · How we verify
NCT00233272
Baltimore Longitudinal Study of Aging
trial in Aging in 10,000 participants. Currently enrolling.
Quick facts
| Lead sponsor | National Institute on Aging (NIA) |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 10,000 |
| Start date | 3 February 2014 |
| Sites | 1 location across United States |
Conditions studied
- Aging — all drugs for Aging →
Sponsor
National Institute on Aging (NIA)
Who can join
Adults 20 to 120, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a clinical research program on human aging that began in 1958. Volunteers of different ages join the study when they are healthy, and have follow-up visits for life. Visits last for multiple days. Participants are evaluated for many physical elements as well as for brain function. Physical tests are given. Information on mood, personality, and social aspects of life is also collected. This program has contributed more than any other research project to our understanding of aging. Objectives: \- To characterize the many aspects of the aging process and learn how people can successfully adapt to aging. Eligibility: \- Healthy individuals at least 20 years old. Design: * Participants will receive a booklet and video describing the tests they will take. * During a 3-day visit at the study hospital, participants will take the following tests: * Urine will be collected for 24 hours. Blood samples will be taken. A small piece of muscle tissue may be collected by a needle. * A medical questionnaire and a physical exam will be given. * Participants hearts will be tested, including with blood pressure tests and electronic monitors. They will breathe into a tube to test their lungs. * Participants will perform several exercises, including treadmill walking. * Vision, hearing, and taste will be tested. * Bone and joint X-rays may be taken. * Imaging tests will be given, such as an MRI. * Participants will answer questions to test their mental abilities. * Participants will return for follow-up visits every few years for life. The tests listed above will be given at every visit.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Personality and risk of Alzheimer's disease: new data and meta-analysis.
Terracciano A, Sutin AR, An Y, O'Brien RJ, et al · · 2014 · cited 211× · PMID 23706517 · DOI 10.1016/j.jalz.2013.03.002 -
Personality Associations With Amyloid and Tau: Results From the Baltimore Longitudinal Study of Aging and Meta-analysis.
Terracciano A, Bilgel M, Aschwanden D, Luchetti M, et al · · 2022 · cited 42× · PMID 34663503 · DOI 10.1016/j.biopsych.2021.08.021 -
GIP contributes to islet trihormonal abnormalities in type 2 diabetes.
Chia CW, Odetunde JO, Kim W, Carlson OD, et al · · 2014 · cited 33× · PMID 24712564 · DOI 10.1210/jc.2013-3994 -
Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults.
Armstrong NM, Huang CW, Williams OA, Bilgel M, et al · · 2019 · cited 26× · PMID 30927602 · DOI 10.1016/j.nicl.2019.101769 -
The association between personality and plasma biomarkers of astrogliosis and neuronal injury.
Terracciano A, Walker K, An Y, Luchetti M, et al · · 2023 · cited 16× · PMID 37210782 · DOI 10.1016/j.neurobiolaging.2023.04.011 -
Associations Between Female Sex Hormones and Skeletal Muscle Ageing: The Baltimore Longitudinal Study of Aging.
Critchlow AJ, Alexander SE, Hiam DS, Ferrucci L, et al · · 2025 · cited 13× · PMID 40296368 · DOI 10.1002/jcsm.13786 -
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis.
Chia R, Moaddel R, Kwan JY, Rasheed M, et al · · 2025 · cited 5× · PMID 40830661 · DOI 10.1038/s41591-025-03890-6 -
Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing.
Moberg M, Elango P, Ferrucci L, Spruit MA, et al · · 2015 · cited 4× · PMID 26173468 · DOI 10.1111/eci.12498
Verify or expand the search:
- PubMed search for NCT00233272
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging
Currently open trials in the same condition.
- NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
- NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other National Institute on Aging (NIA) trials
Trials by the same sponsor.
- NCT06274749 — Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Mask · NA · recruiting
- NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
- NCT06912724 — Pediatric Neuroimaging · recruiting
- NCT06273917 — Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With Dementia · NA · completed
- NCT06269653 — Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00233272 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute on Aging (NIA)
- Last refreshed: 27 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00233272.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing